Last reviewed · How we verify
NCT07052604
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
trial in Pneumonia, Ventilator-Associated in 300 participants. Currently enrolling.
15 September 2025
Quick facts
| Lead sponsor | Centre Hospitalier de Saint-Denis |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 15 December 2023 |
| Primary completion | 15 September 2025 |
| Estimated completion | 15 September 2025 |
| Sites | 1 location across France |
Conditions studied
- Pneumonia, Ventilator-Associated — all drugs for Pneumonia, Ventilator-Associated →
- Stenotrophomonas Maltophilia — all drugs for Stenotrophomonas Maltophilia →
- Intensive Care Units — all drugs for Intensive Care Units →
- Anti-Bacterial Agents — all drugs for Anti-Bacterial Agents →
Sponsor
Centre Hospitalier de Saint-Denis
Who can join
18 and older, any sex, with Pneumonia, Ventilator-Associated or Stenotrophomonas Maltophilia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07052604
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pneumonia, Ventilator-Associated
Currently open trials in the same condition.
- NCT06467864 — Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological · recruiting
- NCT05843786 — Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients · Phase 3 · recruiting
- NCT05117125 — Biomarkers for Ventilator-associated Pneumonia · recruiting
Other Centre Hospitalier de Saint-Denis trials
Trials by the same sponsor.
- NCT07204626 — Medical Anthropology and Migrants in Precarious Situations, Cared for in Intensive and Post-intensive Care Units · not yet recruiting
- NCT07206914 — Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital · not yet recruiting
- NCT07200999 — Prevalence of Carriage of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteria in Preterm Premature Rupture · not yet recruiting
- NCT07170137 — Comparison of Uterine Distension in Hysterosonography Among Patients Monitored for Infertility · recruiting
- NCT07061561 — Objective Evaluation of Cough Effort in Tracheotomized Patients (LOST Study) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07052604 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier de Saint-Denis
- Last refreshed: 4 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07052604.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing